Associate Professor Elizabeth McCusker

Clinical Associate Professor
Medicine, Westmead Clinical School

Telephone +61 2 9845 6793
Fax +61 2 9635 6684

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Paulsen, J., Long, J., Johnson, H., Aylward, E., Ross, C., Williams, J., Nance, M., Erwin, C., Westervelt, H., Harrington, D., McCusker, E., et al (2014). Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience, 6, 1-11. [More Information]
  • McCusker, E., Myers, R. (2014). Feasibility of Huntington disease trials in the disease prodrome. Neurology, 82(10), 824-825. [More Information]
  • Paulsen, J., Nance, M., Kim, J., Carlozzi, N., Panegyres, P., Erwin, C., Goh, A., McCusker, E., Williams, J. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2-28. [More Information]
  • Ramos, E., Latourelle, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Gellera, C., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173-179. [More Information]
  • Loy, C., McCusker, E. (2013). Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease? PLoS Currents, 5, 1-9. [More Information]
  • Biglan, K., Zhang, Y., Long, J., Geschwind, M., Kang, G., Killoran, A., Lu, W., McCusker, E., Mills, J., Raymond, L., et al (2013). Refining the diagnosis of Huntington disease: the PREDICT-HD study. Frontiers in Aging Neuroscience, 5(April 2013), 1-8. [More Information]
  • McCusker, E., Gunn, D., Epping, E., Loy, C., Radford, K., Griffith, J., Mills, J., Long, J., Paulsen, J. (2013). Unawareness of motor phenoconversion in Huntington disease. Neurology, 81(13), 1141-1147. [More Information]
  • Lee, J., Ramos, E., Lee, J., Gillis, T., Mysore, J., Hayden, M., Warby, S., Morrison, P., Nance, M., Ross, C., Trent, R., McCusker, E., et al (2012). CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology, 78(10), 690-695. [More Information]
  • Ramos, E., Latourelle, J., Lee, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). Population stratification may bias analysis of PGC-1(alpha) as a modifier of age at Huntington disease motor onset. Human Genetics, 131(12), 1833-1840. [More Information]
  • Lee, J., Lee, J., Ramos, E., Gillis, T., Mysore, J., Kishikawa, S., Hadzi, T., Hendricks, A., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404-408. [More Information]
  • Gabery, S., Murphy, K., Schultz, K., Loy, C., McCusker, E., Kirik, D., Halliday, G., Petersen, A. (2010). Changes in Key Hypothalamic Neuropeptide Populations in Huntington Disease Revealed by Neuropathological Analyses. Acta Neophilologica, 120, 777-788. [More Information]
  • Li, J., Hayden, M., Warby, S., Durr, A., Morrison, P., Nance, M., Ross, C., Margolis, R., Rosenblatt, A., Trent, R., McCusker, E., et al (2006). Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Medical Genetics, 7, 71-71. [More Information]
  • Kipps, C., Duggins, A., Mahant, N., Gomes, L., Ashburner, J., McCusker, E. (2005). Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Journal of Neurology, Neurosurgery and Psychiatry, 76(5), 650-5. [More Information]
  • Mahant, N., McCusker, E., Byth Wilson, K., Graham, S., The Huntington Study Group. (2003). Huntington's disease: Clinical correlates of disability and progression. Neurology, 61(8), 1085-1092.
  • Thieben, M., Duggins, A., Good, C., Gomes, L., Mahant, N., Richards, F., McCusker, E., Frackowiak, R. (2002). The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain, 125(8), 1815-1828.
  • McCusker, E., Richards, F., Sillence, D., Wilson, M., Trent, R. (2000). Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. Journal of Clinical Neuroscience.

2014

  • Paulsen, J., Long, J., Johnson, H., Aylward, E., Ross, C., Williams, J., Nance, M., Erwin, C., Westervelt, H., Harrington, D., McCusker, E., et al (2014). Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience, 6, 1-11. [More Information]
  • McCusker, E., Myers, R. (2014). Feasibility of Huntington disease trials in the disease prodrome. Neurology, 82(10), 824-825. [More Information]

2013

  • Paulsen, J., Nance, M., Kim, J., Carlozzi, N., Panegyres, P., Erwin, C., Goh, A., McCusker, E., Williams, J. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2-28. [More Information]
  • Ramos, E., Latourelle, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Gellera, C., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2013). Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics, 14(3-4), 173-179. [More Information]
  • Loy, C., McCusker, E. (2013). Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease? PLoS Currents, 5, 1-9. [More Information]
  • Biglan, K., Zhang, Y., Long, J., Geschwind, M., Kang, G., Killoran, A., Lu, W., McCusker, E., Mills, J., Raymond, L., et al (2013). Refining the diagnosis of Huntington disease: the PREDICT-HD study. Frontiers in Aging Neuroscience, 5(April 2013), 1-8. [More Information]
  • McCusker, E., Gunn, D., Epping, E., Loy, C., Radford, K., Griffith, J., Mills, J., Long, J., Paulsen, J. (2013). Unawareness of motor phenoconversion in Huntington disease. Neurology, 81(13), 1141-1147. [More Information]

2012

  • Lee, J., Ramos, E., Lee, J., Gillis, T., Mysore, J., Hayden, M., Warby, S., Morrison, P., Nance, M., Ross, C., Trent, R., McCusker, E., et al (2012). CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology, 78(10), 690-695. [More Information]
  • Ramos, E., Latourelle, J., Lee, J., Gillis, T., Mysore, J., Squitieri, F., Di Pardo, A., Di Donato, S., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). Population stratification may bias analysis of PGC-1(alpha) as a modifier of age at Huntington disease motor onset. Human Genetics, 131(12), 1833-1840. [More Information]
  • Lee, J., Lee, J., Ramos, E., Gillis, T., Mysore, J., Kishikawa, S., Hadzi, T., Hendricks, A., Hayden, M., Morrison, P., Trent, R., McCusker, E., et al (2012). TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochemical and Biophysical Research Communications, 424(3), 404-408. [More Information]

2010

  • Gabery, S., Murphy, K., Schultz, K., Loy, C., McCusker, E., Kirik, D., Halliday, G., Petersen, A. (2010). Changes in Key Hypothalamic Neuropeptide Populations in Huntington Disease Revealed by Neuropathological Analyses. Acta Neophilologica, 120, 777-788. [More Information]

2006

  • Li, J., Hayden, M., Warby, S., Durr, A., Morrison, P., Nance, M., Ross, C., Margolis, R., Rosenblatt, A., Trent, R., McCusker, E., et al (2006). Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Medical Genetics, 7, 71-71. [More Information]

2005

  • Kipps, C., Duggins, A., Mahant, N., Gomes, L., Ashburner, J., McCusker, E. (2005). Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Journal of Neurology, Neurosurgery and Psychiatry, 76(5), 650-5. [More Information]

2003

  • Mahant, N., McCusker, E., Byth Wilson, K., Graham, S., The Huntington Study Group. (2003). Huntington's disease: Clinical correlates of disability and progression. Neurology, 61(8), 1085-1092.

2002

  • Thieben, M., Duggins, A., Good, C., Gomes, L., Mahant, N., Richards, F., McCusker, E., Frackowiak, R. (2002). The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain, 125(8), 1815-1828.

2000

  • McCusker, E., Richards, F., Sillence, D., Wilson, M., Trent, R. (2000). Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. Journal of Clinical Neuroscience.

To update your profile click here. For support on your academic profile contact .